litlas
Log inCreate account

Ulrich Laufs

Active 1997–2025

252
Papers
48,865
Citations
105
h-index
237
i10-index

Citations

Citations per year for Ulrich Laufs1969: 1 citations1985: 1 citations1991: 1 citations1994: 1 citations1996: 1 citations1997: 2 citations1998: 12 citations1999: 40 citations2000: 92 citations2001: 179 citations2002: 259 citations2003: 337 citations2004: 319 citations2005: 367 citations2006: 346 citations2007: 280 citations2008: 322 citations2009: 210 citations2010: 226 citations2011: 222 citations2012: 217 citations2013: 240 citations2014: 213 citations2015: 155 citations2016: 201 citations2017: 245 citations2018: 234 citations2019: 1,060 citations2020: 1,649 citations2021: 2,028 citations2022: 1,672 citations2023: 1,389 citations2024: 2,173 citations2025: 974 citations2026: 64 citations1970–1984: no citations, so these years are not shown1986–1990: no citations, so these years are not shown1992–1993: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,751 citing papers, 18.2% of this breakdownChina: 1,976 citing papers, 9.6% of this breakdownGermany: 1,564 citing papers, 7.6% of this breakdownUnited Kingdom: 1,433 citing papers, 6.9% of this breakdownItaly: 1,185 citing papers, 5.7% of this breakdownCanada: 721 citing papers, 3.5% of this breakdownNetherlands: 651 citing papers, 3.2% of this breakdownSpain: 638 citing papers, 3.1% of this breakdownAustralia: 610 citing papers, 3% of this breakdownFrance: 546 citing papers, 2.6% of this breakdownJapan: 485 citing papers, 2.4% of this breakdownPoland: 451 citing papers, 2.2% of this breakdown
0%18.2%Other 32%

Institutions

Fields

  • Medicine70.1%
  • Biochemistry, Genetics and Molecular Biology18.4%
  • Immunology and Microbiology3.3%
  • Neuroscience3%
  • Nursing1.3%
  • Engineering0.5%
  • Other3.4%

Topics

  • Lipoproteins and Cardiovascular Health10.3%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.6%
  • Atherosclerosis and Cardiovascular Diseases2.6%
  • Cancer, Lipids, and Metabolism2.6%
  • Cholesterol and Lipid Metabolism1.6%
  • Adipokines, Inflammation, and Metabolic Diseases1.4%
  • Other76.9%

Coauthors

All papers

Open in search
  1. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

    Authors: François Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimón, M. John Chapman, Guy De Backer, Victoria Delgado, Brian A. Ference, Ian Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja‐Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Chris P Gale, Diederick E. Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Basil S. Lewis, Bela Merkely, Christian Mueller, Steffen E. Petersen, Anna Sonia Petronio, Dimitrios J. Richter, Marco Roffi, Е. V. Shlyakhto, Iain A. Simpson, Miguel Sousa‐Uva, Rhian M. Touyz, Djamaleddine Nibouche, Parounak Zelveian, Peter Siostrzonek, Ruslan Najafov, Philippe van de Borne, Belma Pojskić, Arman Postadzhiyan, Lambros Kypris, Jindřich Špinar, Mogens Lytken Larsen, Hesham Salah Eldin, Margus Viigimaa, Timo Strandberg, Jean Ferrières, Rusudan Agladze, Ulrich Laufs, Loukianos Rallidis, László Bajnok, Thorbjörn Gudjónsson, Vincent Maher, Yaakov Henkin, Michele Massimo Gulizia, A Mussagaliyeva, Gani Bajraktari, Alina Kerimkulova, Gustavs Latkovskis, Omar Hamoui, Rimvydas Šlapikas, Laurent Visser, Philip Dingli, Victoria Ivanov, Aneta Bošković, M Nazzi, Frank L.J. Visseren, Irena Mitevska, Kjetil Retterstøl, Piotr Jankowski, Ricardo Fontes‐Carvalho, Dan Gaiță, М. В. Ежов, Marina Foscoli, Vojislav Giga, Daniel Pella, Zlatko Fras, Leopoldo Pérez de Isla, Emil Hagström, Roger Lehmann, Leïla Abid, Öner Özdoğan, Olena Mitchenko, Riyaz Patel - Atherosclerosis 2019 cited by 4,864

  2. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Authors: Brian A. Ference, Henry N. Ginsberg, Ian Graham, Kausik K. Ray, Chris J. Packard, Éric Bruckert, Robert A. Hegele, Ronald M. Krauss, Frederick J. Raal, Heribert Schunkert, Gerald F. Watts, Jan Borén, Sergio Fazio, Jay D. Horton, L. Masana, Stephen J. Nicholls, Børge G. Nordestgaard, Bart van de Sluis, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Ulf Landmesser, Ulrich Laufs, Olov Wiklund, Jane K. Stock, M. John Chapman, Alberico L. Catapano - European Heart Journal 2017 cited by 3,840

  3. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Authors: Jan Borén, M. John Chapman, Ronald M. Krauss, Chris J. Packard, Jacob Fog Bentzon, Christoph J. Binder, Mat J.A.P. Daemen, Linda L. Demer, Robert A. Hegele, Stephen J. Nicholls, Børge G. Nordestgaard, Gerald F. Watts, Éric Bruckert, Sergio Fazio, Brian A. Ference, Ian Graham, Jay D. Horton, Ulf Landmesser, Ulrich Laufs, L. Masana, Gerard Pasterkamp, Frederick J. Raal, Kausik K. Ray, Heribert Schunkert, Marja‐Riitta Taskinen, Bart van de Sluis, Olov Wiklund, Lâle Tokgözoğlu, Alberico L. Catapano, Henry N. Ginsberg - European Heart Journal 2020 cited by 1,527

  4. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis

    Authors: Susanne Gaul, Aleksandra Leszczynska, Fernando Alegre, Benedikt Kaufmann, Casey D. Johnson, Leon A. Adams, Alexander Wree, Georg Damm, Daniel Seehofer, Carolina Jiménez Calvente, Davide Povero, Tatiana Kisseleva, Akiko Eguchi, Matthew D. McGeough, Hal M. Hoffman, Pablo Pelegrı́n, Ulrich Laufs, Ariel E. Feldstein - Journal of Hepatology 2020 cited by 544

  5. Pleiotropic Effects of Statins on the Cardiovascular System

    Authors: Adam Oesterle, Ulrich Laufs, James K. Liao - Circulation Research 2017 cited by 1,211

  6. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

    Authors: Kausik K. Ray, Inaam Haq, Aikaterini Bilitou, Marius C. Manu, Annie Burden, Carlos Aguíar, Marcello Arca, Derek Connolly, Mats Eriksson, Jean Ferrières, Ulrich Laufs, José María Mostaza, David Nanchen, Ernst Rietzschel, Timo Strandberg, Hermann Toplak, Frank L.J. Visseren, Alberico L. Catapano - The Lancet Regional Health - Europe 2023 cited by 308

  7. Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease

    Authors: Brian A. Ference, John J.P. Kastelein, Kausik K. Ray, Henry N. Ginsberg, M. John Chapman, Chris J. Packard, Ulrich Laufs, Clare Oliver‐Williams, Angela Wood, Adam S. Butterworth, Emanuele Di Angelantonio, John Danesh, Stephen J. Nicholls, Deepak L. Bhatt, Marc S. Sabatine, Alberico L. Catapano - JAMA 2019 cited by 711

  8. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Authors: Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini, Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Éric Bruckert, Guy De Backer, Ronald M. Krauss, Ulrich Laufs, Raúl D. Santos, Robert A. Hegele, G. Kees Hovingh, Lawrence A. Leiter, François Mach, Winfried März, Connie B. Newman, Olov Wiklund, Terry A. Jacobson, Alberico L. Catapano, M. John Chapman, Henry N. Ginsberg, European Atherosclerosis Society Consensus Panel, Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini, Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Eric Bruckert, Ronald M. Krauss, Ulrich Laufs, Raul D. Santos, Winfried März, Connie B. Newman, M. John Chapman, Henry N. Ginsberg, M. John Chapman, Henry N. Ginsberg, Guy De Backer, Alberico L. Catapano, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Lawrence A. Leiter, François Mach, Olov Wiklund - European Heart Journal 2015 cited by 1,420

  9. Clinical review on triglycerides

    Authors: Ulrich Laufs, Klaus G. Parhofer, Henry N. Ginsberg, Robert A. Hegele - European Heart Journal 2019 cited by 542

  10. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

    Authors: Christie M. Ballantyne, Ulrich Laufs, Kausik K. Ray, Lawrence A. Leiter, Harold Bays, Anne C. Goldberg, Erik S.G. Stroes, Diane MacDougall, Xin Zhao, Alberico L. Catapano - European Journal of Preventive Cardiology 2019 cited by 360

  11. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    Authors: Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons, Kanika Dharmayat, Tomáš Freiberger, G. Kees Hovingh, Pedro Mata, Frederick J. Raal, Raúl D. Santos, Handrean Soran, Gerald F. Watts, Marianne Abifadel, Carlos A. Aguilar-Salinas, Khalid F. AlHabib, Mutaz Al-Khnifsawi, Wael Almahmeed, Fahad Alnouri, Rodrigo Alonso, Khalid Al‐Rasadi, Ahmad Al‐Sarraf, Nasreen Al-Sayed, Francisco Araújo, Tester F. Ashavaid, Maciej Banach, Sophie Béliard, Marianne Benn, Christoph J. Binder, Martin P. Bogsrud, Mafalda Bourbon, Krzysztof Chlebus, Pablo Corral, Kairat Davletov, Olivier Descamps, Ronen Durst, М. В. Ежов, Dan Gaiță, Jacques Genest, Urh Grošelj, Mariko Harada‐Shiba, Kirsten B. Holven, Meral Kayıkçıoğlu, Weerapan Khovidhunkit, Katarina Lalić, Gustavs Latkovskis, Ulrich Laufs, Evangelos Liberopoulos, Marcos M. Lima-Martínez, Jie Lin, Vincent Maher, Adéle Marais, Winfried März, Erkin М Мirrakhimov, André R. Miserez, Olena Mitchenko, Hapizah Nawawi, Børge G. Nordestgaard, Andrie G. Panayiotou, György Paragh, Žaneta Petrulionienė, Belma Pojskić, Arman Postadzhiyan, Katarı́na Rašlová, Ashraf Reda, Željko Reiner, Fouzia Sadiq, Wilson E. Sadoh, Heribert Schunkert, Aleksandr B. Shek, Mario Stoll, Erik S.G. Stroes, Ta‐Chen Su, Tavintharan Subramaniam, Andrey V. Susekov, Myra Tilney, Brian Tomlinson, Thanh Huong Truong, Alexandros D. Tselepis, Anne Tybjærg‐Hansen, Alejandra Cárdenas, Margus Viigimaa, Luya Wang, Shizuya Yamashita, John J.P. Kastelein, Éric Bruckert, Branislav Vohnout, Laura Schreier, Jing Pang, Christoph Ebenbichler, Hans Dieplinger, Reinhold Innerhofer, Yvonne Winhofer-Stöckl, Susanne Greber‐Platzer, Konstantin A. Krychtiuk, Walter S. Speidl, Hermann Toplak, Kurt Widhalm, Thomas M. Stulnig, Kurt Huber, Florian Höllerl, Gersina Rega‐Kaun and 624 more - The Lancet 2021 cited by 305

  12. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance

    Authors: Ulrich Laufs, Maciej Banach, G.B. John Mancini, Daniel Gaudet, LeAnne T. Bloedon, Lulu Ren Sterling, Stephanie Kelly, Erik S.G. Stroes - Journal of the American Heart Association 2019 cited by 433

  13. PLEIOTROPIC EFFECTS OF STATINS

    Authors: James K. Liao, Ulrich Laufs - The Annual Review of Pharmacology and Toxicology 2004 cited by 1,962

  14. Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure

    Authors: Alexander Nickel, Albrecht von Hardenberg, Mathias Hohl, Joachim Löffler, Michael Kohlhaas, Janne Becker, Jan‐Christian Reil, Andrey Kazakov, Julia Bonnekoh, Moritz Stadelmaier, Sarah‐Lena Puhl, Michael Wagner, Ivan Bogeski, Sonia Cortassa, Reinhard Kappl, Bastian Pasieka, Michael LaFontaine, C. Roy D. Lancaster, Thomas S. Blacker, Andrew Hall, Michael R. Duchen, Lars Kästner, Peter Lipp, Tanja Zeller, Christian Müller, Andreas Knopp, Ulrich Laufs, Michael Böhm, Markus Hoth, Christoph Maack - Cell Metabolism 2015 cited by 374

  15. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

    Authors: François Mach, Kausik K. Ray, Olov Wiklund, Alberto Corsini, Alberico L. Catapano, Éric Bruckert, Guy De Backer, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Ronald M. Krauss, Ulrich Laufs, Lawrence A. Leiter, Winfried März, Børge G. Nordestgaard, Frederick J. Raal, Michael Roden, Raúl D. Santos, Evan A. Stein, Erik S.G. Stroes, Paul D Thompson, Lâle Tokgözoğlu, Georgirene D. Vladutiu, Bariş Gencer, Jane K. Stock, Henry N. Ginsberg, M. John Chapman, European Atherosclerosis Society Consensus Panel - European Heart Journal 2018 cited by 381

  16. Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation

    Authors: Stephen Zewinger, Jochen Reiser, Vera Jankowski, Dalia Alansary, Eunsil Hahm, Sarah Triem, Mira Klug, Stefan Schunk, David Schmit, Rafael Kramann, Christina Körbel, Emmanuel Ampofo, Matthias W. Laschke, Simina‐Ramona Selejan, Anna Paschen, Tobias Herter, Susanne Schuster, Günther Silbernagel, Martina Sester, Urban Sester, G. Aßmann, Robert Bals, Gerhard M. Kostner, Willi Jahnen‐Dechent, Michael D. Menger, Lucia Rohrer, Winfried März, Michael Böhm, Joachim Jankowski, Manfred Köpf, Eicke Latz, Barbara A. Niemeyer, Danilo Fliser, Ulrich Laufs, Thimoteus Speer - Nature Immunology 2019 cited by 274

  17. Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease

    Authors: Stefan Schunk, Sarah Triem, David Schmit, Stephen Zewinger, Tamim Sarakpi, Ellen Becker, Gregor Hütter, Selina Wrublewsky, Fabienne Küting, Mathias Hohl, Dalia Alansary, Letícia Prates Roma, Peter Lipp, Julia Möllmann, Michael Lehrke, Matthias W. Laschke, Michael D. Menger, Rafael Kramann, Peter Boor, Willi Jahnen‐Dechent, Winfried März, Michael Böhm, Ulrich Laufs, Barbara A. Niemeyer, Danilo Fliser, Emmanuel Ampofo, Thimoteus Speer - Circulation 2021 cited by 97

  18. Combination lipid-lowering therapy as first-line strategy in very high-risk patients

    Authors: Kausik K. Ray, Laurens F. Reeskamp, Ulrich Laufs, Maciej Banach, François Mach, Lâle Tokgözoğlu, Derek Connolly, Anja J. Gerrits, Erik S.G. Stroes, L. Masana, John J.P. Kastelein - European Heart Journal 2021 cited by 205

  19. Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease

    Authors: Brian A. Ference, Deepak L. Bhatt, Alberico L. Catapano, Chris J. Packard, Ian Graham, Stephen Kaptoge, Thatcher B. Ference, Qi Guo, Ulrich Laufs, Christian T. Ruff, Arjen J. Cupido, G. Kees Hovingh, John Danesh, Michael V. Holmes, George Davey Smith, Kausik K. Ray, Stephen J. Nicholls, Marc S. Sabatine - JAMA 2019 cited by 222

  20. What is ‘remnant cholesterol’?

    Authors: Paulina Stürzebecher, Julius L. Katzmann, Ulrich Laufs - European Heart Journal 2023 cited by 112

  21. Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses

    Authors: Paulina Stürzebecher, Jessica J Schorr, Sven Klebs, Ulrich Laufs - Atherosclerosis 2023 cited by 56

  22. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk

    Authors: Brian A. Ference, John J.P. Kastelein, Henry N. Ginsberg, M. John Chapman, Stephen J. Nicholls, Kausik K. Ray, Chris J. Packard, Ulrich Laufs, Robert D. Brook, Clare Oliver‐Williams, Adam S. Butterworth, John Danesh, George Davey Smith, Alberico L. Catapano, Marc S. Sabatine - JAMA 2017 cited by 328

  23. Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall

    Authors: Christian Werner, Tobias Fürster, Thomas Widmann, Janine Pöss, Cristiana Roggia, Milad Hanhoun, Jürgen Scharhag, Nicole Büchner, Tim Meyer, Wilfried Kindermann, Judith Haendeler, Michael Böhm, Ulrich Laufs - Circulation 2009 cited by 382

  24. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia

    Authors: Maciej Banach, P. Barton Duell, Antonio M. Gotto, Ulrich Laufs, Lawrence A. Leiter, G.B. John Mancini, Kausik K. Ray, JoAnn D Flaim, Zhan Ye, Alberico L. Catapano - JAMA Cardiology 2020 cited by 190